Eyenuk secures $26 Million Series A funding to accelerate global access to AI-powered eye-screening technology
Legacy MEDSearch
OCTOBER 20, 2022
The capital raise was led by AXA IM Alts and was joined by new and existing investors including T&W Medical A/S, A&C Foelsgaard Alternativer ApS, Kendall Capital Partners, and KOFA Healthcare. Contact us to discuss partnering with Legacy MedSearch on your position. Eyenuk, Inc., Are you hiring?
Let's personalize your content